Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: Novel Chinese Medicine Formula for Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a novel Chinese medicine formulation for type 2 diabetes mellitus is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel Chinese Medicine Formula for Diabetes

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Type 2 Diabetes | Phase 2 | Status: NOT_YET_RECRUITING